LegalizeCommission Delegated Regulation (EU) 2016/128 of 25 September 2015 supplementing Regulation (EU) No 609/2013 of the European Parliament and of the Council as regards the specific compositional and information requirements for food for special medical purposes (Text with EEA relevance)
Article 1
Placing on the market
Food for special medical purposes may only be placed on the market if it complies with this Regulation.
Article 2
Compositional requirements
Food for special medical purposes is classified in the following three categories:
(a) nutritionally complete food with a standard nutrient formulation which, used in accordance with the manufacturer's instructions, may constitute the sole source of nourishment for the persons for whom it is intended;
(b) nutritionally complete food with a nutrient-adapted formulation specific for a disease, disorder or medical condition which, used in accordance with the manufacturer's instructions, may constitute the sole source of nourishment for the persons for whom it is intended;
(c) nutritionally incomplete food with a standard formulation or a nutrient-adapted formulation specific for a disease, disorder or medical condition which is not suitable to be used as the sole source of nourishment.
The food referred to in points (a) and (b) of the first subparagraph may also be used as a partial replacement or as a supplement to the patient's diet.
Food for special medical purposes other than that developed to satisfy the nutritional requirements of infants shall comply with the compositional requirements set out in Part B of Annex I.
Article 3
Requirements on pesticides in food for special medical purposes developed to satisfy the nutritional requirements of infants and young children
Those levels shall be determined by generally accepted standardised analytical methods.
However, for the purpose of checks, plant protection products containing the active substances listed in Annex III are considered not to have been used if their residues do not exceed a level of 0,003 mg/kg.
Article 4
Name of the food
The name of food for special medical purposes shall be as set out in Annex IV.
Article 5
Specific requirements on food information
In addition to the mandatory particulars listed in Article 9(1) of Regulation (EU) No 1169/2011, the following shall be additional mandatory particulars for food for special medical purposes:
(a) a statement that the product must be used under medical supervision;
(b) a statement whether the product is suitable for use as the sole source of nourishment;
(c) a statement that the product is intended for a specific age group, as appropriate;
(d) where appropriate, a statement that the product poses a health hazard when consumed by persons who do not have the disease, disorder or medical condition for which the product is intended;
(e) the statement ‘For the dietary management of …’ where the blank shall be filled in with the disease, disorder or medical condition for which the product is intended;
(f) where appropriate, a statement concerning adequate precautions and contra-indications;
(g) a description of the properties and/or characteristics that make the product useful in relation to the disease, disorder or medical condition for the dietary management of which the product is intended, in particular, as the case may be, relating to the special processing and formulation, the nutrients which have been increased, reduced, eliminated or otherwise modified and the rationale of the use of the product;
(h) where appropriate, a warning that the product is not for parenteral use;
(i) instructions for appropriate preparation, use and storage of the product after the opening of the container, as appropriate.
The particulars referred to in points (a) to (d) shall be preceded by the words ‘important notice’ or their equivalent.
Article 6
Specific requirements on the nutrition declaration
In addition to the information referred to in Article 30(1) of Regulation (EU) No 1169/2011, the mandatory nutrition declaration for food for special medical purposes shall include the following:
(a) the amount of each mineral substance and of each vitamin listed in Annex I to this Regulation and present in the product;
(b) the amount of components of protein, carbohydrate, fat and/or of other nutrients and their components, the declaration of which would be necessary for the appropriate intended use of the product;
(c) information on the osmolality or the osmolarity of the product where appropriate;
(d) information on the source and the nature of the protein and/or protein hydrolysates contained in the product.
Particulars not listed in Annex XV to Regulation (EU) No 1169/2011 that do not belong to or are not components of any of the entries of that Annex shall be presented in the nutrition declaration after the last entry of that Annex.
The indication of the amount of sodium shall appear together with the other minerals and may be repeated next to the indication of the salt content as follows: ‘Salt: X g (of which sodium: Y mg)’.
Article 7
Nutrition and health claims
Nutrition and health claims shall not be made on food for special medical purposes.
Article 8
Specific requirements for food for special medical purposes developed to satisfy the nutritional requirements of infants
However, graphic representations for easy identification of the product and for illustrating methods of preparation shall be permitted.
Member States may further restrict or prohibit such advertising. Such advertising shall contain only information of a scientific and factual nature.
The first and second subparagraphs shall not prevent the dissemination of information exclusively intended for health care professionals.
Article 9
Notification
When food for special medical purposes is placed on the market, the food business operator shall notify the competent authority of each Member State where the product concerned is being marketed of the information appearing on the label, by sending to it a model of the label used for the product, and of any other information the competent authority may reasonably request to establish compliance with this Regulation, unless a Member State exempts the food business operator from that obligation under a national system that guarantees an efficient official monitoring of the product concerned.
Article 10
Directive 1999/21/EC
In accordance with Article 20(4) of Regulation (EU) No 609/2013, Directive 1999/21/EC is repealed with effect from 22 February 2019. However, Directive 1999/21/EC shall continue to apply until 21 February 2020 to food for special medical purposes developed to satisfy the nutritional requirements of infants.
References to Directive 1999/21/EC in other acts shall be construed as references to this Regulation in accordance with the scheme set out in the first paragraph.
Article 11
Entry into force and application
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
It shall apply from 22 February 2019, except in respect of food for special medical purposes developed to satisfy the nutritional requirements of infants, to which it shall apply from 22 February 2020.
For the purposes of the second subparagraph of Article 21(1) of Regulation (EU) No 609/2013, in respect of food for special medical purposes developed to satisfy the nutritional requirements of infants the later date referred to in the second paragraph of this Article shall be considered as the date of application.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
COMPOSITIONAL REQUIREMENTS REFERRED TO IN ARTICLE 2(3)
PART A
Food for special medical purposes developed to satisfy the nutritional requirements of infants
1.Products referred to in Article 2(1)(a) developed to satisfy the nutritional requirements of infants shall contain the vitamins and mineral substances as specified in Table 1.
2.Products referred to in Article 2(1)(b) developed to satisfy the nutritional requirements of infants shall contain the vitamins and mineral substances as specified in Table 1, without prejudice to modifications for one or more of these nutrients rendered necessary by the intended use of the product.
3.Maximum levels of vitamins and mineral substances present in products referred to in Article 2(1)(c) developed to satisfy the nutritional requirements of infants shall not exceed those specified in Table 1, without prejudice to modifications for one or more of these nutrients rendered necessary by the intended use of the product.
4.Where this is not contrary to the requirements dictated by the intended use, food for special medical purposes developed to satisfy the nutritional requirements of infants shall comply with the provisions relating to other nutrients applicable to infant formula and follow-on formula, as the case may be, laid down in Commission Delegated Regulation (EU) 2016/127 (1).
| Per 100 kJ | Per 100 kcal | |||
|---|---|---|---|---|
| Minimum | Maximum | Minimum | Maximum | |
| Vitamins | ||||
| Vitamin A (μg-RE) (1) | 16,7 | 43 | 70 | 180 |
| Vitamin D (μg) | 0,48 | 0,72 | 2 | 3 |
| Vitamin K (μg) | 0,24 | 6 | 1 | 25 |
| Vitamin C (mg) | 0,96 | 7,2 | 4 | 30 |
| Thiamin (μg) | 9,6 | 72 | 40 | 300 |
| Riboflavin (μg) | 14,3 | 107 | 60 | 450 |
| Vitamin B6 (μg) | 4,8 | 72 | 20 | 300 |
| Niacin (mg) (2) | 0,1 | 0,72 | 0,4 | 3 |
| Folate (μg-DFE) (3) | 3,6 | 11,4 | 15 | 47,6 |
| Vitamin B12 (μg) | 0,02 | 0,12 | 0,1 | 0,5 |
| Panthotenic Acid (mg) | 0,1 | 0,48 | 0,4 | 2 |
| Biotin (μg) | 0,24 | 4,8 | 1 | 20 |
| Vitamin E (mg α-tocopherol) (4) | 0,14 | 1,2 | 0,6 | 5 |
| Minerals | ||||
| Sodium (mg) | 6 | 14,3 | 25 | 60 |
| Chloride (mg) | 14,3 | 38,2 | 60 | 160 |
| Potassium (mg) | 19,1 | 38,2 | 80 | 160 |
| Calcium (mg) (5) | 12 | 60 | 50 | 250 |
| Phosphorus (mg) (6) | 6 | 24 | 25 | 100 |
| Magnesium (mg) | 1,2 | 3,6 | 5 | 15 |
| Iron (mg) | 0,07 | 0,6 | 0,3 | 2,5 |
| Zinc (mg) | 0,12 | 0,6 | 0,5 | 2,4 |
| Copper (μg) | 14,3 | 29 | 60 | 120 |
| Iodine (μg) | 3,6 | 8,4 | 15 | 35 |
| Selenium (μg) | 0,72 | 2 | 3 | 8,6 |
| Manganese (μg) | 0,24 | 24 | 1 | 100 |
| Chromium (μg) | — | 2,4 | — | 10 |
| Molybdenum (μg) | — | 3,3 | — | 14 |
| Fluoride (μg) | — | 47,8 | — | 200 |
| (1) Preformed vitamin A; RE = all trans retinol equivalent. (2) Preformed niacin. (3) Dietary folate equivalent: 1 μg DFE = 1 μg food folate = 0,6 μg folic acid from food for special medical purposes. (4) Based on vitamin E activity of RRR-α-tocopherol. (5) The calcium:available phosphorus molar ratio shall not be less than 1 nor greater than 2. (6) Total phosphorus. |
PART B
Food for special medical purposes other than that developed to satisfy the nutritional requirements of infants
1.Products referred to in Article 2(1)(a) other than those developed to satisfy the nutritional requirements of infants shall contain the vitamins and mineral substances as specified in Table 2.
2.Products referred to in Article 2(1)(b) other than those developed to satisfy the nutritional requirements of infants shall contain the vitamins and mineral substances as specified in Table 2, without prejudice to modifications for one or more of these nutrients rendered necessary by the intended use of the product.
3.Maximum levels of vitamins and mineral substances present in products referred to in Article 2(1)(c) other than those developed to satisfy the nutritional requirements of infants shall not exceed those specified in Table 2, without prejudice to modifications for one or more of these nutrients rendered necessary by the intended use of the product.
| Per 100 kJ | Per 100 kcal | |||
|---|---|---|---|---|
| Minimum | Maximum | Minimum | Maximum | |
| Vitamins | ||||
| Vitamin A (μg-RE) | 8,4 | 43 | 35 | 180 |
| Vitamin D (μg) | 0,12 | 0,65/0,75 (1) | 0,5 | 2,5/3 (1) |
| Vitamin K (μg) | 0,85 | 5 | 3,5 | 20 |
| Vitamin C (mg) | 0,54 | 5,25 | 2,25 | 22 |
| Thiamin (mg) | 0,015 | 0,12 | 0,06 | 0,5 |
| Riboflavin (mg) | 0,02 | 0,12 | 0,08 | 0,5 |
| Vitamin B6 (mg) | 0,02 | 0,12 | 0,08 | 0,5 |
| Niacin (mg NE) | 0,22 | 0,75 | 0,9 | 3 |
| Folic Acid (μg) | 2,5 | 12,5 | 10 | 50 |
| Vitamin B12 (μg) | 0,017 | 0,17 | 0,07 | 0,7 |
| Panthotenic Acid (mg) | 0,035 | 0,35 | 0,15 | 1,5 |
| Biotin (μg) | 0,18 | 1,8 | 0,75 | 7,5 |
| Vitamin E (mg α-TE) | 0,5/g of polyunsaturated fatty acids expressed as linoleic acid but in no case less than 0,1 mg per 100 available kJ | 0,75 | 0,5/g of polyunsaturated fatty acids expressed as linoleic acid but in no case less than 0,5 mg per 100 available kcal | 3 |
| Minerals | ||||
| Sodium (mg) | 7,2 | 42 | 30 | 175 |
| Chloride (mg) | 7,2 | 42 | 30 | 175 |
| Potassium (mg) | 19 | 70 | 80 | 295 |
| Calcium (mg) | 8,4/12 (1) | 42/60 (1) | 35/50 (1) | 175/250 (1) |
| Phosphorus (mg) | 7,2 | 19 | 30 | 80 |
| Magnesium (mg) | 1,8 | 6 | 7,5 | 25 |
| Iron (mg) | 0,12 | 0,5 | 0,5 | 2 |
| Zinc (mg) | 0,12 | 0,36 | 0,5 | 1,5 |
| Copper (μg) | 15 | 125 | 60 | 500 |
| Iodine (μg) | 1,55 | 8,4 | 6,5 | 35 |
| Selenium (μg) | 0,6 | 2,5 | 2,5 | 10 |
| Manganese (mg) | 0,012 | 0,12 | 0,05 | 0,5 |
| Chromium (μg) | 0,3 | 3,6 | 1,25 | 15 |
| Molybdenum (μg) | 0,84 | 4,3 | 3,5 | 18 |
| Fluoride (mg) | — | 0,05 | — | 0,2 |
| (1) For products intended for children of 1 to 10 years of age. |
ANNEX II
| Chemical name of the parent compound of the substance 1 | Maximum residue level (mg/kg) |
|---|---|
| Cadusafos | 0,006 |
| Demeton-S-methyl Demeton-S-methyl sulfone Oxydemeton-methyl | 0,006 |
| Ethoprophos | 0,008 |
| Fipronil | 0,004 |
| Propineb | 0,006 |
ANNEX III
| Chemical name of the parent compound of the substance (1) |
|---|
| Aldrin Dieldrin Disulfoton Endrin Fensulfothion Fentin Haloxyfop Heptachlor Hexachlorobenzene Nitrofen Omethoate Terbufos |
| (1) The most updated residue definition applies as set out in the relevant Annexes II, III, IV or V to Regulation (EC) No 396/2005 (the residue definition is mentioned in brackets behind the parent compound of the substance). |
ANNEX IV
NAME REFERRED TO IN ARTICLE 4
The name of food for special medical purposes shall be respectively:
— in Bulgarian: ‘Храни за специални медицински цели’,
— in Spanish: ‘Alimento para usos médicos especiales’,
— in Czech: ‘Potravina pro zvláštní lékařské účely’,
— in Danish: ‘Fødevare til særlige medicinske formål’,
— in German: ‘Lebensmittel für besondere medizinische Zwecke (bilanzierte Diät)’,
— in Estonian: ‘Meditsiinilisel näidustusel kasutamiseks ettenähtud toit’,
— in Greek: ‘Τρόφιμα για ειδικούς ιατρικούς σκοπούς’,
— in English: ‘Food for special medical purposes’,
— in French: ‘Denrée alimentaire destinée à des fins médicales spéciales’,
— in Croatian: ‘Hrana za posebne medicinske potrebe’,
— in Italian: ‘Alimento a fini medici speciali’,
— in Latvian: ‘Īpašiem medicīniskiem nolūkiem paredzēta pārtika’,
— in Lithuanian: ‘Specialios medicininės paskirties maisto produktai’,
— in Hungarian: ‘Speciális gyógyászati célra szánt élelmiszer’,
— in Maltese: ‘Ikel għal skopijiet mediċi speċjali’,
— in Dutch: ‘Voeding voor medisch gebruik’,
— in Polish: ‘Żywność specjalnego przeznaczenia medycznego’,
— in Portuguese: ‘Alimento para fins medicinais específicos’,
— in Romanian: ‘Alimente destinate unor scopuri medicale speciale’,
— in Slovak: ‘Potraviny na osobitné lekárske účely’,
— in Slovenian: ‘Živila za posebne zdravstvene namene’,
— in Finnish: ‘Erityisiin lääkinnällisiin tarkoituksiin tarkoitettu elintarvike (kliininen ravintovalmiste)’,
— in Swedish: ‘Livsmedel för speciella medicinska ändamål’.
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.